Your browser doesn't support javascript.
loading
Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?
Moll, Guido; Hult, Annika; von Bahr, Lena; Alm, Jessica J; Heldring, Nina; Hamad, Osama A; Stenbeck-Funke, Lillemor; Larsson, Stella; Teramura, Yuji; Roelofs, Helene; Nilsson, Bo; Fibbe, Willem E; Olsson, Martin L; Le Blanc, Katarina.
Affiliation
  • Moll G; Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hult A; Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • von Bahr L; Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden ; Hematology Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Alm JJ; Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Heldring N; Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hamad OA; Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • Stenbeck-Funke L; Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • Larsson S; Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Teramura Y; Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • Roelofs H; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
  • Nilsson B; Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • Fibbe WE; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
  • Olsson ML; Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Le Blanc K; Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden ; Hematology Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.
PLoS One ; 9(1): e85040, 2014.
Article in En | MEDLINE | ID: mdl-24454787
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ABO Blood-Group System / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Child / Humans / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: Sweden Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ABO Blood-Group System / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Child / Humans / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: Sweden Country of publication: United States